Matches in Wikidata for { <http://www.wikidata.org/entity/Q90391404> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q90391404 description "artículu científicu espublizáu en xunetu de 2018" @default.
- Q90391404 description "scientific article published on 19 July 2018" @default.
- Q90391404 description "wetenschappelijk artikel" @default.
- Q90391404 description "наукова стаття, опублікована в липні 2018" @default.
- Q90391404 name "Post-hoc analysis of two clinical trials examining Customized Adherence Enhancement plus long acting injectable antipsychotic (CAE-L) in high-risk individuals with serious mental illness" @default.
- Q90391404 name "Post-hoc analysis of two clinical trials examining Customized Adherence Enhancement plus long acting injectable antipsychotic (CAE-L) in high-risk individuals with serious mental illness" @default.
- Q90391404 type Item @default.
- Q90391404 label "Post-hoc analysis of two clinical trials examining Customized Adherence Enhancement plus long acting injectable antipsychotic (CAE-L) in high-risk individuals with serious mental illness" @default.
- Q90391404 label "Post-hoc analysis of two clinical trials examining Customized Adherence Enhancement plus long acting injectable antipsychotic (CAE-L) in high-risk individuals with serious mental illness" @default.
- Q90391404 prefLabel "Post-hoc analysis of two clinical trials examining Customized Adherence Enhancement plus long acting injectable antipsychotic (CAE-L) in high-risk individuals with serious mental illness" @default.
- Q90391404 prefLabel "Post-hoc analysis of two clinical trials examining Customized Adherence Enhancement plus long acting injectable antipsychotic (CAE-L) in high-risk individuals with serious mental illness" @default.
- Q90391404 P1433 Q90391404-FC109968-F28E-47EF-8E51-FFC5DB8A56F8 @default.
- Q90391404 P1476 Q90391404-605BF092-0731-4C56-96F3-CEB336D6654C @default.
- Q90391404 P2093 Q90391404-7AA1612F-1DA3-4BA9-94DB-252683B03D9A @default.
- Q90391404 P2093 Q90391404-AAC1015E-2A65-422E-B029-C0D1B7D7BAD2 @default.
- Q90391404 P2093 Q90391404-BB613CB6-5A67-4767-84F3-05CEC40542D2 @default.
- Q90391404 P2093 Q90391404-E1D4B70D-5BC7-4FBF-B20A-0BE3FEB4C680 @default.
- Q90391404 P2093 Q90391404-E7AB9187-8DFC-431D-A962-EBE0585F9030 @default.
- Q90391404 P304 Q90391404-13C31FE2-CC6E-41CE-B59C-7AAA9ABE24B9 @default.
- Q90391404 P31 Q90391404-E6B5FB2B-2503-4924-8F1C-92EACEBF265A @default.
- Q90391404 P356 Q90391404-F7EED9F9-18D3-47D5-AE7A-A35C9890E12F @default.
- Q90391404 P478 Q90391404-E5A67DD6-3133-45B6-B5E3-84D032103A7F @default.
- Q90391404 P50 Q90391404-2F938A18-1EE7-4D50-98A0-4009B0B17669 @default.
- Q90391404 P577 Q90391404-47A36314-EF35-414C-A9F1-53A4F9039570 @default.
- Q90391404 P698 Q90391404-4F12260D-B25A-427D-AB78-95004B748718 @default.
- Q90391404 P921 Q90391404-980E195D-0BAA-4F8B-91DE-77E5F3BE6CB7 @default.
- Q90391404 P356 J.SCHRES.2018.07.024 @default.
- Q90391404 P698 30032936 @default.
- Q90391404 P1433 Q7431607 @default.
- Q90391404 P1476 "Post-hoc analysis of two clinical trials examining Customized Adherence Enhancement plus long acting injectable antipsychotic (CAE-L) in high-risk individuals with serious mental illness" @default.
- Q90391404 P2093 "Christine M Collins" @default.
- Q90391404 P2093 "Curtis Tatsuoka" @default.
- Q90391404 P2093 "Jennifer B Levin" @default.
- Q90391404 P2093 "Kristin A Cassidy" @default.
- Q90391404 P2093 "Michelle E Aebi" @default.
- Q90391404 P304 "433-434" @default.
- Q90391404 P31 Q13442814 @default.
- Q90391404 P356 "10.1016/J.SCHRES.2018.07.024" @default.
- Q90391404 P478 "202" @default.
- Q90391404 P50 Q107320342 @default.
- Q90391404 P577 "2018-07-19T00:00:00Z" @default.
- Q90391404 P698 "30032936" @default.
- Q90391404 P921 Q19365224 @default.